Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/9/2024 | $35.00 | Mkt Perform → Outperform | Barrington Research |
| 5/6/2024 | $50.00 | Hold → Buy | Lake Street |
| 2/23/2024 | $60.00 → $40.00 | Buy → Hold | Deutsche Bank |
| 2/23/2024 | $60.00 → $39.00 | Buy → Hold | Jefferies |
| 8/3/2022 | $145.00 | Overweight | Stephens |
| 2/28/2022 | $190.00 → $155.00 | Outperform | Barrington Research |
| 2/3/2022 | $180.00 → $150.00 | Buy | Deutsche Bank |
| 12/17/2021 | $180.00 | Buy | Deutsche Bank |
8-K - ModivCare Inc (0001220754) (Filer)
8-K - ModivCare Inc (0001220754) (Filer)
NT 10-Q - ModivCare Inc (0001220754) (Filer)
4 - ModivCare Inc (0001220754) (Issuer)
4 - ModivCare Inc (0001220754) (Issuer)
4 - ModivCare Inc (0001220754) (Issuer)
Seasoned Executive Daniel Silvers Brings Decades of Experience in Corporate Finance, Capital Allocation and Public Company Governance Modivcare Inc. ("Modivcare" or the "Company") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Daniel Silvers has been appointed to its board of directors (the "Board"), effective April 24, 2025. The appointment of Mr. Silvers completes the Board's previously announced plan to add three new independent directors pursuant to its contractual obligations with its lenders. "We welcome Mr. Silvers to the Board and are confide
Financial and Healthcare Executive Erin L. Russell Brings Decades of Experience in Healthcare Capital Markets and Strategy Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company providing a platform of integrated supportive care solutions focused on improving health outcomes, today announced that Erin L. Russell has been appointed to its board of directors (the "Board"), effective February 10, 2025. Ms. Russell brings more than 25 years of experience in the healthcare and financial sectors, with a distinguished track record in capital and credit markets. On the Board, Ms. Russell will be a member of the Audit and Nominating and Govern
NEW YORK, March 27, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: Solventum Corp. (NYSE:SOLV) will be added to the S&P 500 effective prior to the open of trading on Monday, April 1, replacing V.F. Corp. (NYSE:VFC), which will be moved to the S&P SmallCap 600 effective prior to the open of trading on Wednesday, April 3. V.F. will replace ModivCare Inc. (NASD: MODV) in the S&P SmallCap 600 also effective prior to the open of trading on April 3. S&P 500 and 100 constituent 3M Co. (NYSE:MMM) is spinning off Solventum in a transaction expected to be completed April 1. Following the spin-off, the parent 3M will rema
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today reported financial results for the three months ended March 31, 2025. "In Q1, we continued to advance our strategic objectives and operational initiatives," said L. Heath Sampson, President and CEO. "Company-wide alignment on key initiatives—securing new contracts, laying the groundwork for scalable automation, reducing G&A, strengthening our working-capital discipline, and progressing toward divestiture readiness—positions us to deliver enhanced performance and long-term va
Modivcare Inc. ("Modivcare" or the "Company") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced that the Company is scheduled to report financial results for the first quarter ended March 31, 2025, on Thursday, May 8, 2025, after the market closes and host a conference call at 5:00 p.m. Eastern Time the same day. The conference call dial-in number for domestic callers is (877) 407-8037, and international callers should dial +1 (201) 689-8037. Interested parties may also access the live webcast via the Company's website at: https://investors.modivcare.com/even
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions focused on improving patient outcomes, today reported financial results for the three months and full year ended December 31, 2024. Fourth Quarter 2024 Summary: Service revenue of $702.8 million, remaining consistent with the fourth quarter of 2023 Net loss of $23.5 million, or negative $1.64 per diluted common share Adjusted EBITDA(1) of $40.4 million, adjusted net income(1) of $2.7 million and adjusted EPS(1) of $0.19 per diluted common share Net cash provided by operating activities during the quarter of $30.0
SC 13D/A - ModivCare Inc (0001220754) (Subject)
SC 13D/A - ModivCare Inc (0001220754) (Subject)
SC 13D/A - ModivCare Inc (0001220754) (Subject)
Barrington Research upgraded ModivCare from Mkt Perform to Outperform and set a new price target of $35.00
Lake Street upgraded ModivCare from Hold to Buy and set a new price target of $50.00
Deutsche Bank downgraded ModivCare from Buy to Hold and set a new price target of $40.00 from $60.00 previously
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, announced that, on August 21, 2025, the Company was notified by the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") that Nasdaq had determined to commence proceedings to delist the Company's common stock as a result of the Company's commencement of voluntary proceedings under Chapter 11 of the United States Bankruptcy Code on August 20, 2025. Information regarding the Company's plans to implement, through expedited bankruptcy proceedings, a comprehensive
Supermajority support of secured lenders outlined in Restructuring Support Agreement and via commitment for $100 million in a new investment to support operations and the future growth of the Company Operations and service lines continue uninterrupted, with no expected impact for clients, members, employees or transportation providers Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company providing a platform of integrated supportive care solutions focused on improving health outcomes, today announced that it has taken necessary and decisive action intended to strengthen its financial foundation while continuing to provide access to
Modivcare Inc. (the "Company" or "Modivcare") (NASDAQ:MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving health outcomes, today announced it has regained compliance with Rule 5450(b)(3)(C) of the Nasdaq Stock Market LLC ("Nasdaq") regarding the Company's market value of publicly held shares ("MVPHS"). On July 7, 2025, the Company received confirmation from Nasdaq that it regained compliance with the MVPHS requirement for continued listing on Nasdaq, having confirmed that the Company's MVPHS had been above $15 million for at least the last 20 consecutive business days. Accordingly, the Company again
4 - ModivCare Inc (0001220754) (Issuer)
3 - ModivCare Inc (0001220754) (Issuer)
3 - ModivCare Inc (0001220754) (Issuer)